An Open-label Study to Evaluate the Effect of MabThera in Combination With Methotrexate on Treatment Response in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.
Phase of Trial: Phase IV
Latest Information Update: 03 Dec 2014
At a glance
- Drugs Rituximab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 21 Aug 2009 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 15 Nov 2007 Status changed from recruiting to in progress.